ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anlotinib Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-27P5705
Home | Market Reports | Health| Pharmacy
Global Anlotinib Market Insights and Forecast to 2028
BUY CHAPTERS

Global Anlotinib Market Research Report 2025

Code: QYRE-Auto-27P5705
Report
September 2025
Pages:66
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Chia Tai Tianqing

Anlotinib Market

The global market for Anlotinib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Anlotinib is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Anlotinib is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Anlotinib in Non-small Cell Lung Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Anlotinib include CHIA TAI TIANQING, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anlotinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anlotinib.
The Anlotinib market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anlotinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anlotinib companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anlotinib Market Report

Report Metric Details
Report Name Anlotinib Market
Segment by Type
  • 8mg Capsules
  • 10mg Capsules
  • 12mg Capsules
Segment by Application
  • Non-small Cell Lung Cancer
  • Ovarian Cancer
  • Soft Tissue Sarcoma
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CHIA TAI TIANQING
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Anlotinib company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anlotinib Market report?

Ans: The main players in the Anlotinib Market are CHIA TAI TIANQING

What are the Application segmentation covered in the Anlotinib Market report?

Ans: The Applications covered in the Anlotinib Market report are Non-small Cell Lung Cancer, Ovarian Cancer, Soft Tissue Sarcoma, Others

What are the Type segmentation covered in the Anlotinib Market report?

Ans: The Types covered in the Anlotinib Market report are 8mg Capsules, 10mg Capsules, 12mg Capsules

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anlotinib Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 8mg Capsules
1.2.3 10mg Capsules
1.2.4 12mg Capsules
1.3 Market by Application
1.3.1 Global Anlotinib Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Non-small Cell Lung Cancer
1.3.3 Ovarian Cancer
1.3.4 Soft Tissue Sarcoma
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anlotinib Market Perspective (2020-2031)
2.2 Global Anlotinib Growth Trends by Region
2.2.1 Global Anlotinib Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anlotinib Historic Market Size by Region (2020-2025)
2.2.3 Anlotinib Forecasted Market Size by Region (2026-2031)
2.3 Anlotinib Market Dynamics
2.3.1 Anlotinib Industry Trends
2.3.2 Anlotinib Market Drivers
2.3.3 Anlotinib Market Challenges
2.3.4 Anlotinib Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anlotinib Players by Revenue
3.1.1 Global Top Anlotinib Players by Revenue (2020-2025)
3.1.2 Global Anlotinib Revenue Market Share by Players (2020-2025)
3.2 Global Anlotinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anlotinib Revenue
3.4 Global Anlotinib Market Concentration Ratio
3.4.1 Global Anlotinib Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anlotinib Revenue in 2024
3.5 Global Key Players of Anlotinib Head office and Area Served
3.6 Global Key Players of Anlotinib, Product and Application
3.7 Global Key Players of Anlotinib, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anlotinib Breakdown Data by Type
4.1 Global Anlotinib Historic Market Size by Type (2020-2025)
4.2 Global Anlotinib Forecasted Market Size by Type (2026-2031)
5 Anlotinib Breakdown Data by Application
5.1 Global Anlotinib Historic Market Size by Application (2020-2025)
5.2 Global Anlotinib Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anlotinib Market Size (2020-2031)
6.2 North America Anlotinib Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anlotinib Market Size by Country (2020-2025)
6.4 North America Anlotinib Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anlotinib Market Size (2020-2031)
7.2 Europe Anlotinib Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anlotinib Market Size by Country (2020-2025)
7.4 Europe Anlotinib Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anlotinib Market Size (2020-2031)
8.2 Asia-Pacific Anlotinib Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anlotinib Market Size by Region (2020-2025)
8.4 Asia-Pacific Anlotinib Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anlotinib Market Size (2020-2031)
9.2 Latin America Anlotinib Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anlotinib Market Size by Country (2020-2025)
9.4 Latin America Anlotinib Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anlotinib Market Size (2020-2031)
10.2 Middle East & Africa Anlotinib Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anlotinib Market Size by Country (2020-2025)
10.4 Middle East & Africa Anlotinib Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CHIA TAI TIANQING
11.1.1 CHIA TAI TIANQING Company Details
11.1.2 CHIA TAI TIANQING Business Overview
11.1.3 CHIA TAI TIANQING Anlotinib Introduction
11.1.4 CHIA TAI TIANQING Revenue in Anlotinib Business (2020-2025)
11.1.5 CHIA TAI TIANQING Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Chia Tai Tianqing
List of Tables
 Table 1. Global Anlotinib Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of 8mg Capsules
 Table 3. Key Players of 10mg Capsules
 Table 4. Key Players of 12mg Capsules
 Table 5. Global Anlotinib Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Anlotinib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Anlotinib Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Anlotinib Market Share by Region (2020-2025)
 Table 9. Global Anlotinib Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Anlotinib Market Share by Region (2026-2031)
 Table 11. Anlotinib Market Trends
 Table 12. Anlotinib Market Drivers
 Table 13. Anlotinib Market Challenges
 Table 14. Anlotinib Market Restraints
 Table 15. Global Anlotinib Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Anlotinib Market Share by Players (2020-2025)
 Table 17. Global Top Anlotinib Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anlotinib as of 2024)
 Table 18. Ranking of Global Top Anlotinib Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Anlotinib Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Anlotinib, Headquarters and Area Served
 Table 21. Global Key Players of Anlotinib, Product and Application
 Table 22. Global Key Players of Anlotinib, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Anlotinib Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Anlotinib Revenue Market Share by Type (2020-2025)
 Table 26. Global Anlotinib Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Anlotinib Revenue Market Share by Type (2026-2031)
 Table 28. Global Anlotinib Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Anlotinib Revenue Market Share by Application (2020-2025)
 Table 30. Global Anlotinib Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Anlotinib Revenue Market Share by Application (2026-2031)
 Table 32. North America Anlotinib Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Anlotinib Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Anlotinib Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Anlotinib Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Anlotinib Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Anlotinib Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Anlotinib Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Anlotinib Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Anlotinib Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Anlotinib Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Anlotinib Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Anlotinib Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Anlotinib Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Anlotinib Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Anlotinib Market Size by Country (2026-2031) & (US$ Million)
 Table 47. CHIA TAI TIANQING Company Details
 Table 48. CHIA TAI TIANQING Business Overview
 Table 49. CHIA TAI TIANQING Anlotinib Product
 Table 50. CHIA TAI TIANQING Revenue in Anlotinib Business (2020-2025) & (US$ Million)
 Table 51. CHIA TAI TIANQING Recent Development
 Table 52. Research Programs/Design for This Report
 Table 53. Key Data Information from Secondary Sources
 Table 54. Key Data Information from Primary Sources
 Table 55. Authors List of This Report


List of Figures
 Figure 1. Anlotinib Picture
 Figure 2. Global Anlotinib Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anlotinib Market Share by Type: 2024 VS 2031
 Figure 4. 8mg Capsules Features
 Figure 5. 10mg Capsules Features
 Figure 6. 12mg Capsules Features
 Figure 7. Global Anlotinib Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Anlotinib Market Share by Application: 2024 VS 2031
 Figure 9. Non-small Cell Lung Cancer Case Studies
 Figure 10. Ovarian Cancer Case Studies
 Figure 11. Soft Tissue Sarcoma Case Studies
 Figure 12. Others Case Studies
 Figure 13. Anlotinib Report Years Considered
 Figure 14. Global Anlotinib Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Anlotinib Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Anlotinib Market Share by Region: 2024 VS 2031
 Figure 17. Global Anlotinib Market Share by Players in 2024
 Figure 18. Global Top Anlotinib Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anlotinib as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Anlotinib Revenue in 2024
 Figure 20. North America Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Anlotinib Market Share by Country (2020-2031)
 Figure 22. United States Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Anlotinib Market Share by Country (2020-2031)
 Figure 26. Germany Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Anlotinib Market Share by Region (2020-2031)
 Figure 34. China Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Anlotinib Market Share by Country (2020-2031)
 Figure 42. Mexico Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Anlotinib Market Share by Country (2020-2031)
 Figure 46. Turkey Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Anlotinib Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. CHIA TAI TIANQING Revenue Growth Rate in Anlotinib Business (2020-2025)
 Figure 50. Bottom-up and Top-down Approaches for This Report
 Figure 51. Data Triangulation
 Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Erlotinib Market Research Report 2024
Global Neratinib Market Research Report 2024
Global Nilotinib Hydrochloride Market Research Report 2025
Global Fostamatinib Market Research Report 2024
Nilotinib Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Crizotinib Market Research Report 2024
Global Afatinib Market Research Report 2024
Global Ibrutinib Market Research Report 2024
Global Ruxolitinib Market Research Report 2024
Global Erlotinib HCl Market Research Report 2025
Global Erlotinib Hydrochloride Market Research Report 2024
Global Pyrotinib Market Research Report 2024
Global Apatinib Market Research Report 2024
Global Lorlatinib Market Research Report 2024
Global Gefitinib Market Research Report 2024
Global Ceritinib Market Research Report 2024
Global Pazopanib Market Research Report 2024
Global Tucatinib Market Research Report 2025
Fostamatinib Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alectinib Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions